Partnering will also likely lead to accessing additional expertise in how to run global trials and in particular the overall co-ordination. I'd personally gain more confidence in timelines if they had someone that has been through the process before.
Ann: Quarterly Update and Appendix 4C - quarterly, page-26
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $83.98M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 4156 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.5¢ | 10227 | 2 |
View Market Depth
| Last trade - 10.02am 18/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
Day chart unavailable